Furthermore, by Cox regression analysis, LEP hypermethylation could severe as a prognostic biomarker independently affecting OS among total AML with a trend (P = 0.052, Table 4) and non-M3 AML patients (P = 0.041, Table 5). This evidence concerns the gene LEP and acute myeloid leukemia.